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Methods: Adult subjects with primary diagnosis of acute drug overdose were prospectively enrolled at two urban, tertiary care hospitals; one of which served as a very racially diverse population. The race of enrollees was based on subject or family report. The computer determination of the initial ED ECG (utilized Bazett's correction) was used for analysis and compared to gender norms. Information of the reported ingested substance was recorded. Data were analyzed using logistic regression that focused on four variables. Power calculation set a study inclusion target of 466 subjects.
Results: Four hundred seventy-two subjects were analyzed. The majority were male (54 %) and mean age of 42 years. Racial distribution included Hispanic (32 %), white (32 %), black (17 %), and Asian (8 %). The most common reported ingested drugs included opioids, benzodiazepines, sympathomimetics, and anti-psychotics. Drugs known to cause prolonged QT duration were reported in 131 cases. The main study findings included an increased risk of QT prolongation in blacks (OR 2.0, CI 1.03-3.91) and decreased risk in Hispanics (OR 0.5, CI 0.29-0.94). Multidrug ingestions involving methadone were associated with a prolonged QT, but oxycodone was the only individual drug with a positive association.
Conclusion: Investigators concluded that race was a more important factor than drug class in assessing risk of QT prolongation following acute overdose.
Critique: This prospective study encompasses a relatively large subject population with information abstracted in a standardized manner and QTc information derived using Bazett's calculation. The association of QT prolongation and oxycodone is interesting, since oxycodone is not known to cause cardiac conduction abnormalities. The study has limitations including the ever present, formidable obstacle of analytical drug confirmation for many of the subjects. Data collection could have been more robust: only a single ECG was used for each subject in the study and clinical outcomes associated with QT prolongation such as dysrhythmias or mortality were not collected. The investigators accounted in part for known population differences in QT intervals by using gender-specific values to compare the study subjects. However, the design did not take into account known ethnic differences. Is there sufficient pre-existing QT data to have used both gender and race values from healthy individuals as control values, not just simply different gender values? Lastly, other QTc variables were not accounted for in the study including diurnal variation and electrolyte abnormalities.
Implication for toxicologists: Within the limitations, the study demonstrates that potential cardiotoxic risk of QT prolonging drugs may vary depending on race. Additionally, more vigilance may be warranted for ECG abnormalities due to oxycodone exposure. Background: Little information regarding the medical outcomes following A. piscivorus (cottonmouth or water moccasin) envenomation has been published.
Research question: The study sought to describe medical outcomes of cottonmouth snakebites over a 29 year period and to assess the impact of crotalidae polyvalent ovine fab on medical outcomes.
Methods: Investigators analyzed cottonmouth snakebite data in the annual national poison center database reports from 1983-2011. Standard poison center database outcomes were utilized (fatal, major, moderate, etc.). Outcomes were indexed by number of exposures and analyzed via negative binomial/ Poisson regression.
Results: Investigators found a relationship over time between cottonmouth bites with no effect and those with moderate effect. The prevalence of bites with no effect has decreased over the time period of poison center data collection. Bites with moderate effect increased over time. Authors noted one death. There was no association between outcome trends and introduction of new fab antivenom in 2001.
Conclusions: Cottonmouth bites with no effect are decreasing and those with moderate effects are increasing. Annual outcome rates were not affected by fab antivenom availability.
Critique: This is the largest comprehensive report of cottonmouth outcomes to date, involving approximately 2,100 bites over 29 years. Although comprehensive, the study has inherent limitations associated with poison center data that readers are likely familiar with and that the authors acknowledge. Additionally, the study outcomes were not specific to envenomation (such as envenomation grade) but based on accepted standard general poison center definitions. Antivenom treatment was a secondary outcome variable in the study, but the raw data contained only outcomes and no treatment information. Lastly, as overall, mortality is extremely low after North American Crotalinae bites, functional outcomes (such as recovery time, lost work, etc.) may be more important measures. Unfortunately, annual poison center data is not currently amenable to such outcome analysis.
Implications for toxicologists: Because rattlesnake and copperhead envenomations are far more prevalent than cottonmouth bites, they receive nearly all the attention in the medical literature. The last comprehensive report focusing on cottonmouth bites was published in 1967 (Parris et al. South Med J 1967; 60:429-34) . The only recent report evaluated outcomes in a smaller subset of poison center data. The current study demonstrates an increase in cottonmouth bites with outcomes that may warrant treatment. However, the value of any treatment, including antivenom, cannot be determined from the study. Further scrutiny is needed to identify manifestations that might benefit from treatment and the role of crotalidae fab therapy after envenomation with this snake species.
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Background: Synthetic cannabinoids have received a great deal of media attention due to increasing recreational use and potential medicinal use. However, the clinical effects are not well characterized.
Research question: This case series (n=2) raises the question of potential stroke complications associated with acute synthetic cannabis use.
Methodology: Authors describe two young women that developed acute ischemic right middle cerebral artery distribution infarcts in temporal relation to smoking synthetic cannabis. Both patients suffered significant neurological deficits. Their diagnostic evaluation included positive urine drug screen for THC in one case and both had negative hypercoagulability studies.
Conclusion: Authors promote awareness of possible ischemic stroke consequences of synthetic cannabis use.
Critique: This is an intriguing and worrisome report. The author's concerns must be somewhat tempered as the two patients were not totally free of risk factors for stroke (use of prescribed amphetamine derivative, tobacco use, estrogen birth control, and previous intra-cranial hemorrhage). Details of the hypercoagulability evaluation were not included.
Implication for toxicologists: Although this report is insufficient to assign causality, it prompts further vigilance.
